Vallon Pharmaceuticals, Inc.
(NASDAQ : VLON)

( )
VLON After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.25%162.640.7%$1229.36m
PFEPfizer Inc. 0.99%38.950.9%$1049.85m
MRKMerck & Co., Inc. 0.18%77.610.7%$782.74m
ABBVAbbVie, Inc. 0.76%108.731.9%$744.24m
BMYBristol-Myers Squibb Co. 0.44%65.751.0%$703.61m
LLYEli Lilly & Co. 0.25%189.731.1%$539.14m
AZNAstraZeneca Plc 1.75%51.631.2%$494.28m
GSKGlaxoSmithKline Plc 0.64%37.990.2%$223.56m
NVSNovartis AG 0.40%88.370.2%$162.95m
VTRSViatris, Inc. -1.12%13.250.0%$124.35m
CVACCureVac NV 3.40%113.000.0%$103.24m
RPRXRoyalty Pharma Plc -0.24%41.770.2%$91.76m
RGENRepligen Corp. -0.59%212.046.8%$80.03m
NVONovo Nordisk A/S 0.75%72.710.1%$62.90m
SNYSanofi 1.01%51.820.2%$59.75m

Company Profile

Vallon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on the development and commercialization of proprietary biopharmaceutical products. The firm's primary product is Abuse-Deterrent Amphetamine Immediate and its product pipeline includes ADAIR, ADMIR, ADHD, and Narcolepsy. The company was founded by David C. Baker on January 11, 2018 and is headquartered in Philadelphia, PA.